Chiron Real Estate Inc. (NYSE: XRN) Stock Analysis & Fundamentals

XRNChiron Real Estate Inc.

NYSE · US · Real Estate · REIT - Healthcare Facilities · chironre.com

38.07USD+3.76%Mkt Cap: 598.43M $P/E: —1d ago

Chiron Real Estate Inc. is a real estate investment trust focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital, and real estate. Chiron Real Estate I…

Industry Peers

REIT - Healthcare Facilities

Omega Healthcare Investors, Inc.

$15.55BUSDP/E 24.1

DOC

Healthpeak Properties, Inc.

Healthcare Realty Trust Incorporated

Chartwell Retirement Residences

$5.42BUSDP/E Infinity

SBRA

Sabra Health Care REIT, Inc.

$5.08BUSDP/E 32.0

NHI

National Health Investors, Inc.

$3.84BUSDP/E 25.5

MPT

Medical Properties Trust, Inc.

$2.88BUSD

PHP

Primary Health Properties Plc

$2.62BUSDP/E 13.3

DHC

Diversified Healthcare Trust

National Healthcare Properties, Inc.

$1.15BUSD

CPINV

Care Property Invest NV

$585.39MUSDP/E 8.4

UHT

Universal Health Realty Income Trust

$607.75MUSDP/E 34.2

CHCT

Community Healthcare Trust Incorporated

$530.86MUSDP/E 154.8

STRW

Strawberry Fields REIT, Inc.

$184.88MUSDP/E 21.5

Indicators:|

Key Statistics

Company

Market Cap598.43M $

Enterprise Value1.31B $

Revenue (TTM)151.53M $

Gross Profit115.06M $

Net Income (TTM)-5.84M $

Revenue/Share11.36 USD

Last Price38.07 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees30

CountryUS

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-24.88

PEG5.09

EV/EBITDA14.33

EV/Revenue8.64

P/S3.95

P/B1.34

EPS (TTM)-1.13

EPS (Forward)-1.53

52W Range

29.0583% of range39.93

52W High39.93 USD

52W Low29.05 USD

Profitability

Gross Margin77.91%

Oper. Margin23.35%

EBITDA Margin60.32%

Profit Margin-3.95%

ROE-1.14%

ROA-0.47%

Growth

Revenue Growth10.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF73.61M $

CapEx (TTM)81.69M $

FCF Margin64.27%

FCF Yield16.28%

Net Debt661.35M $

Net Debt/EBITDA7.24

Balance Sheet

Debt/Equity1.31

Current Ratio0.99

Quick Ratio0.78

Book Value/Sh28.42 USD

Cash/Share1.164 USD

Dividends

Fwd Div Rate5.730 USD

Trail. Div Rate3.370 USD

Div. Yield15.62%

5Y Avg Yield10.00%

Payout Ratio1114.29%

Ex-Div DateJul 20, 2026

Pay DateSep 18, 2026

Splits

Last Split1:5

Split DateSep 22, 2025

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)38.00 USD

Upside (mean)-0.2%

Target Range9.000 USD – 46.00 USD

$9.000-0.2% to mean$46.00

# Analysts8

Ownership

Shares Out.14.48M

Float12.30M

Insiders6.25%

Institutions67.84%

Short Interest

Short Ratio5.8d

Short % Float5.86%

Short % Out.5.55%

Shares Short804.18K

Short (prev mo.)630.18K

Technical

SMA 5036.02 (+5.7%)

SMA 20034.52 (+10.3%)

Beta1.12

S&P 52W Chg19.63%

Avg Vol (30d)83.60K

Avg Vol (10d)68.65K

Technical Indicators

RSI (14)61.8

MACD0.2925

MACD Signal0.2979

MACD Hist.-0.0055

BB Upper38.67 USD

BB Middle36.71 USD

BB Lower34.75 USD

BB Width10.68%

ATR (14)0.9976 USD

Vol Ratio (20d)0.96x